Susquehanna downgrades Obagi Medical Products (Nasdaq: OMPI) to Neutral.

Susquehanna analyst says, "We are decreasing our growth expectations on ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE